Co-Authors
This is a "connection" page, showing publications co-authored by GEORGE R BLUMENSCHEIN and GREGORY GLADISH.
Connection Strength
0.131
-
Phase 1b study of motesanib, an oral angiogenesis inhibitor, in combination with carboplatin/paclitaxel and/or panitumumab for the treatment of advanced non-small cell lung cancer. Clin Cancer Res. 2010 Jan 01; 16(1):279-90.
Score: 0.093
-
Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer. J Thorac Oncol. 2008 Apr; 3(4):351-7.
Score: 0.021
-
Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer. Cancer. 2005 Dec 01; 104(11):2449-56.
Score: 0.017